# Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/favipiravir-versus-arbidol-for-covid-19-a-randomized-clinical-trial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Chang Chen,Yi Zhang,Jianying Huang,Ping Yin,Zhenshun Cheng,Jianyuan Wu,Song Chen,Yongxi Zhang,Bo Chen,Mengxin Lü,Yongwen Luo,Lingao Ju,Jingyi Zhang,Xinghuan Wang |
| Citations | 794 |
| DOI | 10.1101/2020.03.17.20037432 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.medrxiv.org/content/medrxiv/early/2020/04/15/2020.03.17.20037432.full.pdf |
| OpenAlex ID | https://openalex.org/W3011779988 |
| Type | preprint |
| Year | 2020 |

## Paper authors

- [Xinghuan Wang](https://scholariq.org/researchers/xinghuan-wang/)

## Paper journal

- [medRxiv](https://scholariq.org/journals/medrxiv/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Infectious Encephalopathies and Encephalitis](https://scholariq.org/topics/infectious-encephalopathies-and-encephalitis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.